Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis

Ginger Carls, Tracy Li, Pantelis Panopalis, Shaohung Wang, Amy G. Mell, Teresa B. Gibson, Ron Z. Goetzel

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: To estimate the medical- and productivity-related cost burden of systemic lupus erythematosus (SLE) and SLE with nephritis in an employee population. METHODS: Using administrative data, annual costs were calculated for SLE patients, a subset with nephritis, and a matched control group of patients without SLE. These costs were compared with the cost of other chronic conditions. RESULTS: Mean annual medical expenditures and short term disability costs for SLE patients were $12,238 and $1184 greater (2005 dollars), respectively, than those of controls. Mean medical expenditures for SLE/nephritis patients were $46,862 greater than for controls. When compared with other chronic health conditions faced by employees, SLE/nephritis was the most costly condition. CONCLUSIONS: SLE, particularly with nephritis, is associated with substantial costs. Therapies that can better manage SLE may provide opportunities for savings to employers.

Original languageEnglish (US)
Pages (from-to)66-79
Number of pages14
JournalJournal of occupational and environmental medicine
Volume51
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis'. Together they form a unique fingerprint.

  • Cite this